Nicholas Investment Partners, LP Xenon Pharmaceuticals Inc. Transaction History
Nicholas Investment Partners, LP
- $804 Million
- Q1 2025
A detailed history of Nicholas Investment Partners, LP transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 86,968 shares of XENE stock, worth $2.64 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
86,968
Previous 14,658
493.31%
Holding current value
$2.64 Million
Previous $574,000
408.19%
% of portfolio
0.36%
Previous 0.06%
Shares
8 transactions
Others Institutions Holding XENE
# of Institutions
220Shares Held
70.3MCall Options Held
444KPut Options Held
207K-
Avoro Capital Advisors LLC New York, NY5.74MShares$174 Million3.12% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.58MShares$139 Million1.68% of portfolio
-
Wellington Management Group LLP Boston, MA3.79MShares$115 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.33MShares$101 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.09MShares$93.6 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $1.89B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...